EPISTAXIS

Clinical trials for EPISTAXIS explained in plain language.

Never miss a new study

Get alerted when new EPISTAXIS trials appear

Sign up with your email to follow new studies for EPISTAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1 Completed 2

Could a cancer pill stop debilitating nosebleeds? new trial hopes so.

Disease control Ongoing

This study tests whether a low dose of pazopanib, a drug currently used for cancer, can reduce severe nosebleeds and improve anemia in people with hereditary hemorrhagic telangiectasia (HHT). About 70 participants will take either the drug or a placebo daily for 24 weeks. Researc…

Matched conditions: EPISTAXIS

Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

EPISTAXIS

Get alerted when new EPISTAXIS trials appear

Could a cancer pill stop debilitating nosebleeds? new trial hopes so.